Follow
Emma K. Accorsi
Title
Cited by
Cited by
Year
Association between 3 doses of mRNA COVID-19 vaccine and symptomatic infection caused by the SARS-CoV-2 Omicron and Delta variants
EK Accorsi, A Britton, KE Fleming-Dutra, ZR Smith, N Shang, G Derado, ...
Jama 327 (7), 639-651, 2022
6412022
Application of hyperspectral remote sensing to cyanobacterial blooms in inland waters
RM Kudela, SL Palacios, DC Austerberry, EK Accorsi, LS Guild, ...
Remote Sensing of Environment 167, 196-205, 2015
2262015
Effectiveness of bivalent mRNA vaccines in preventing symptomatic SARS-CoV-2 infection—increasing community access to testing program, United States, September–November 2022
R Link-Gelles
MMWR. Morbidity and Mortality Weekly Report 71, 2022
1592022
Association of prior BNT162b2 COVID-19 vaccination with symptomatic SARS-CoV-2 infection in children and adolescents during omicron predominance
KE Fleming-Dutra, A Britton, N Shang, G Derado, R Link-Gelles, ...
Jama 327 (22), 2210-2219, 2022
1392022
How to detect and reduce potential sources of biases in studies of SARS-CoV-2 and COVID-19
EK Accorsi, X Qiu, E Rumpler, L Kennedy-Shaffer, R Kahn, K Joshi, ...
European Journal of Epidemiology 36, 179-196, 2021
1202021
Early Estimates of bivalent mRNA booster dose vaccine effectiveness in preventing symptomatic SARS-CoV-2 infection attributable to Omicron BA. 5–and XBB/XBB. 1.5–related …
R Link-Gelles
MMWR. Morbidity and Mortality Weekly Report 72, 2023
1032023
Association of COVID-19 vaccination with symptomatic SARS-CoV-2 infection by time since vaccination and Delta variant predominance
A Britton, KE Fleming-Dutra, N Shang, ZR Smith, T Dorji, G Derado, ...
Jama 327 (11), 1032-1041, 2022
632022
Effectiveness of homologous and heterologous Covid-19 boosters against Omicron
EK Accorsi, A Britton, N Shang, KE Fleming-Dutra, R Link-Gelles, ...
New England Journal of Medicine 386 (25), 2433-2435, 2022
512022
Use of 15-valent pneumococcal conjugate vaccine among US children: updated recommendations of the Advisory Committee on Immunization Practices—United States, 2022
M Kobayashi
MMWR. Morbidity and Mortality Weekly Report 71, 2022
512022
Whole microbial community viability is not quantitatively reflected by propidium monoazide sequencing approach
Y Wang, Y Yan, KN Thompson, S Bae, EK Accorsi, Y Zhang, J Shen, ...
Microbiome 9, 1-13, 2021
462021
Discovery of bioactive microbial gene products in inflammatory bowel disease
Y Zhang, A Bhosle, S Bae, LJ McIver, G Pishchany, EK Accorsi, ...
Nature 606 (7915), 754-760, 2022
452022
Preliminary estimates of effectiveness of monovalent mRNA vaccines in preventing symptomatic SARS-CoV-2 infection among children aged 3–5 years—Increasing Community Access to …
KE Fleming-Dutra
MMWR. Morbidity and mortality weekly report 72, 2023
262023
Pediatric brain abscesses, epidural empyemas, and subdural empyemas associated with Streptococcus species—United States, January 2016–August 2022
EK Accorsi
MMWR. Morbidity and Mortality Weekly Report 71, 2022
192022
Seroprevalence of anti-SARS-CoV-2 IgG antibodies in the staff of a public school system in the midwestern United States
L Lopez, T Nguyen, G Weber, K Kleimola, M Bereda, Y Liu, EK Accorsi, ...
PLoS One 16 (6), e0243676, 2021
182021
Long-term diet and risk of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection and coronavirus disease 2019 (COVID-19) severity
Y Yue, W Ma, EK Accorsi, M Ding, F Hu, WC Willett, AT Chan, Q Sun, ...
The American Journal of Clinical Nutrition 116 (6), 1672-1681, 2022
172022
Sleeping within six feet: Challenging Oregon’s labor housing COVID-19 guidelines
EK Accorsi, J Samples, LA McCauley, N Shadbeh
Journal of Agromedicine 25 (4), 413-416, 2020
132020
Determinants of Staphylococcus aureus carriage in the developing infant nasal microbiome
EK Accorsi, EA Franzosa, T Hsu, R Joice Cordy, A Maayan-Metzger, ...
Genome biology 21, 1-24, 2020
122020
Extraordinary natural ability: Anagram solution as an extension of normal reading ability
E Accorsi, PW Cho, J Henin, W Tabor
Proceedings of the Annual Meeting of the Cognitive Science Society 31 (31), 2009
72009
Building the US COVID-19 vaccine effectiveness program: Past successes and future directions
R Link-Gelles, A Britton, KE Fleming-Dutra
Vaccine, 2023
42023
Effectiveness of booster doses of monovalent mRNA COVID-19 vaccine against symptomatic severe acute respiratory syndrome Coronavirus 2 infection in children, adolescents, and …
AA Ciesla, RE Wiegand, ZR Smith, A Britton, KE Fleming-Dutra, J Miller, ...
Open Forum Infectious Diseases 10 (5), ofad187, 2023
42023
The system can't perform the operation now. Try again later.
Articles 1–20